| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |